Financials

News Ideas Discussions Technicals Forecast Seasonals

Diluted net income available to common stockholders of CUREVAC NV

Annual data

2019

2020

2021

2022

2023

TTM

‪‪−450.00 M‬‬

‪‪−300.00 M‬‬

‪‪−150.00 M‬‬

‪0.00‬

‪‪150.00 M‬‬

Period

Value

Change

Change %

TTM

‪‪110.92 M‬‬

+‪‪365.75 M‬‬

—

2023

‪‪−254.83 M‬‬

‪‪−10.29 M‬‬

‪−4.21‬%

2022

‪‪−244.54 M‬‬

+‪‪183.60 M‬‬

+‪42.88‬%

2021

‪‪−428.14 M‬‬

‪‪−307.84 M‬‬

‪−255.89‬%

2020

‪‪−120.30 M‬‬

‪‪−20.72 M‬‬

‪−20.81‬%

2019

‪‪−99.58 M‬‬

‪‪−26.06 M‬‬

‪−35.45‬%

Quarterly data

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−130.00 M‬‬

‪0.00‬

‪‪130.00 M‬‬

‪‪260.00 M‬‬

‪‪390.00 M‬‬

Period

Value

Change

Change %

Q3 '24

‪‪333.53 M‬‬

+‪‪406.44 M‬‬

—

Q2 '24

‪‪−72.91 M‬‬

‪‪−1.94 M‬‬

‪−2.74‬%

Q1 '24

‪‪−70.97 M‬‬

+‪‪13.46 M‬‬

+‪15.94‬%

Q4 '23

‪‪−84.43 M‬‬

‪‪−34.33 M‬‬

‪−68.53‬%

Q3 '23

‪‪−50.10 M‬‬

+‪‪17.17 M‬‬

+‪25.52‬%

Q2 '23

‪‪−67.27 M‬‬

‪‪−10.42 M‬‬

‪−18.34‬%

Q1 '23

‪‪−56.84 M‬‬

+‪‪65.90 M‬‬

+‪53.69‬%

Q4 '22

‪‪−122.74 M‬‬

‪‪−73.88 M‬‬

‪−151.20‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20